688319 欧林生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-2.8691.9523.07917.67510.070
总资产报酬率 ROA (%)-1.6211.1361.97511.6526.399
投入资产回报率 ROIC (%)-2.1991.6022.76316.5607.888

边际利润分析
销售毛利率 (%)92.43493.55092.86593.92795.140
营业利润率 (%)-39.9870.6257.60120.85210.349
息税前利润/营业总收入 (%)-35.3394.0918.21221.99111.477
净利润/营业总收入 (%)-38.5542.3064.85422.16211.287

收益指标分析
经营活动净收益/利润总额(%)140.42233.73167.60994.90697.241
价值变动净收益/利润总额(%)-0.0686.6718.4783.5120.595
营业外收支净额/利润总额(%)-3.71880.1594.6565.2318.309

偿债能力分析
流动比率 (X)2.0991.9551.7822.5611.513
速动比率 (X)1.9171.8041.6322.3431.321
资产负债率 (%)43.06142.28239.69430.30241.214
带息债务/全部投入资本 (%)23.36118.65811.3032.665--
股东权益/带息债务 (%)318.726422.883757.4133,545.2454,472.123
股东权益/负债合计 (%)130.401134.475150.186230.013142.637
利息保障倍数 (X)-10.9924.33534.304-1,787.57960.488

营运能力分析
应收账款周转天数 (天)613.678356.438272.293194.9810.000
存货周转天数 (天)1,249.930847.387705.108733.2000.000